Last reviewed · How we verify
NCT05509270
Efficacy of Communication Modalities for Promoting Flu Shots
NA trial testing Letter in Influenza Vaccination in 43,225 participants. Completed in 4 October 2022.
4 October 2022
Quick facts
| Lead sponsor | Geisinger Clinic |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 43,225 |
| Start date | 6 September 2022 |
| Primary completion | 4 October 2022 |
| Estimated completion | 4 October 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Letter
- Patient portal
- SMS
Conditions studied
- Influenza Vaccination — all drugs for Influenza Vaccination →
- Health Promotion — all drugs for Health Promotion →
- Health Behavior — all drugs for Health Behavior →
- Risk Reduction — all drugs for Risk Reduction →
Sponsor
Geisinger Clinic
Who can join
18 and older, any sex, with Influenza Vaccination or Health Promotion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to test which modalities (mailed letter, short message service \[SMS\] text, or patient portal messages) are most effective for encouraging flu shots in high-risk patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05509270
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Letter
Trials testing the same drug.
- NCT06090552 — I CAN DO Surgical ACP · NA · recruiting
- NCT05853848 — Mammogram Mail- and Phone-based Interventions · NA · completed
- NCT04548765 — Evaluation of Letters Promoting Colorectal Cancer Testing · NA · completed
- NCT04051281 — CMO Letter to Reduce Inappropriate Antibiotic Prescribing Winter 2019/2020 · NA · completed
- NCT05226091 — Trial to Assess Implementation of New Research in a Primary Care Setting (TRAINS) · NA · completed
Other recruiting trials for Influenza Vaccination
Currently open trials in the same condition.
- NCT07310472 — Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility · NA · recruiting
- NCT07222774 — Strengthening Intentions · NA · active not recruiting
- NCT04367883 — Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection · recruiting
- NCT03346772 — Study of Immune Responses to Influenza Vaccination · Phase 4 · recruiting
Other Geisinger Clinic trials
Trials by the same sponsor.
- NCT07197801 — Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Diso · NA · recruiting
- NCT06936709 — Perioperative Colchicine for TKA · Phase 4 · not yet recruiting
- NCT07042477 — Integrated Telemedicine Program Evaluation · NA · recruiting
- NCT07028398 — CMSL Ambulatory Sensitive Condition Nudge Study 2 · NA · recruiting
- NCT06696066 — PEERS Pilot: Peer Recovery Support Program to Support Engagement in Medication for Opioid Use Disorder · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05509270 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Geisinger Clinic
- Last refreshed: 12 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05509270.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing